TQB2101 for Injection
TQB2101-I-02
Phase 1 small_molecule active
Quick answer
TQB2101 for Injection for Advanced Hematologic Malignancies is a Phase 1 program (small_molecule) at Nanjing Zenshine Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Nanjing Zenshine Pharmaceuticals
- Indication
- Advanced Hematologic Malignancies
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active